Skip to main content

Table 5 Spearman rho correlations

From: Edema-like symptoms are common in ultra-distance cyclists and driven by overdrinking, use of analgesics and female sex – a study of 919 athletes

 

Ride distance [km]

Ride duration [d]

Daily distance [km/d]

Sex (f = 1, m = 2)

BMI [kg/m2]

Electrolyte intake (no = 0, yes = 1)

Fluid intake [L/d]

Drinking strategy

Analgesic intake (no = 0, yes = 1)

ambient

much

thirst

Swelling Symptoms (total)

.06

[−.02, .14]

.06

[−.02, .14]

−.03

[−.11, .06]

−.22***

[−.29, .13]

.06

[−.02, .14]

−.02

[−.11, .08]

−.02

[−.10, .06]

−.07

[−.15, .92]

.11**

[.03, .19]

−.05

[−.14, .04]

.20***

[.12, .28]

Facial Swelling

.09*

[.01, .17]

.09*

[−.00, .17]

−.02

[−.10, .07]

−.21***

[−.30, −.12]

−.11**

[−.19, −.03]

−0.03

[−.12, .05]

.01

[−.08, .10]

−.01

[−.08, .07]

.04

[−.04, .11]

−.02

[−.09, .07]

.11**

[.02, .18]

Eyelid Swelling

.08*

[.01, .16]

.07(*)

[−.01, .16]

.01

[−.07, .08]

−.18***

[−.27, .08]

−.11*

[−.19, −.04]

.02

[−.06, .10]

−.02

[−.10, .05]

.02

[−.07, .10]

.07(*)

[−.00, .15]

−.05

[−.13, .03]

.10*

[.02, .18]

Swelling of toes/feet

.04

[−.04, .11]

.02

[−.06, .10]

.01

[−.07, .08]

−.06

[−.14, .03]

.05

[−.03, .12]

.01

[−.08, .09]

−.00

[−.07, .08]

−.05

[−.13, .03]

.08*

[.01, .17]

−.05

[−.14, .03]

.18***

[.10, .25]

Swelling of fingers/hands

−.03

[−.11, .05]

−.02

[−.10, .06]

−.02

[−.11, .06]

−.14**

[−.22, .06]

.08*

[.00, .15]

−.06

[−.14, .03]

−.00

[−.09, .07]

−.09*

[−.17, −.01]

.12*

[.04, .20]

−.03

[−.11, .05]

.12*

[.04, .20]

Swelling of extremities

.05

[−.04, .13]

.05

[−.04, .12]

−.03

[−.11, .05]

−.13*

[−.22, .04]

−.03

[−.10, .05]

−.02

[−.10, .06]

−.01

[−.08, .07]

−.05

[−.14, .02]

.07(*)

[−.01, .16]

−.04

[−.12, .04]

.12*

[.04, .20]

Reduced urine output

−.16***

[−.23, −.07]

−.12**

[−.19, −.04]

−.02

[−.09, .07]

−.06

[−.14, .02]

−.00

[−.09, .08]

.04

[−.04, .13]

.01

[−.07, .09]

−.03

[−.11, .05]

.05

[−.03, .13]

.03

[−.04, .12]

.01

[−.07, .09]

Increased urine output

.09*

[.01, .18]

.08*

[−.00, .16]

−.00

[−.08, .08]

−.03

[−.11, .06]

−.06

[−.14, .01]

.05

[−.03, .11]

.05

[−.03, .13]

−.00

[−.08, .08]

−.01

[−.08, .07]

−.07

[−.15, .01]

.02

[−.05, .10]

Concentrated/darker urine

−.12**

[−.21, −.04]

−.10*

[−.17, −.02]

−.01

[−.09, .06]

.03

[−.10, .12]

.08*

[−.00, .16]

.07

[−.03, .16]

−.05

[−.13, .03]

−.13**

[−.21, −.05]

.04

[−.04, .12]

.08(*)

[−.01, .16]

−.01

[− 10, .06]

Less concentrated/lighter urine

.02

[−.06, .09]

.01

[−.07, .09]

.01

[−.08, .10]

−.02

[−.10, .06]

−.04

[−.12, .05]

−.03

[−.11, .05]

.09*

[.02, .17]

.01

[−.07, .09]

.03

[−.05, .11]

−.07(*)

[−.14, .01]

.02

[−.06, .10]

Bubbly/Foamy urine

−.01

[−.09, .08]

−.02

[−.10, .06]

.01

[−.07, .09]

.02

[−.06, .08]

−.03

[−.11, .06]

.05

[−.02, .09]

−.03

[−.12, .04]

−.05

[−.14, .03]

−.03

[−.11, .05]

.06

[−.03, .15]

.04

[−.04, .13]

  1. Parentheses indicate 95% confidence intervals. Levels of significance: (*): marginal significance p < .10, *: p < 0.05, **: p < 0.01, ***: p < 0.001. Abbreviations: body mass index (BMI)
Back to article page

Journal of the International Society of Sports Nutrition

ISSN: 1550-2783

Contact us